Medtronic Announces Japanese Regulatory Approval for Micra(TM) Transcatheter Pacing System (TPS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
February 21, 2017 1:38 PM ESTNeedham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $84.00) while maintaining a Buy rating. 3Q revenue was $7.283B vs. consensus estimates of $7.221B and adjusted EPS was $1.12 vs. consensus of $1.11.
Analyst Mike Matson commented, "F3Q17 revenue and... More
